HomePortfoliosRusi Kiryazov
Optimize
None Rebalancing
EUR
Moderate Risk
4.1yr backtest

Performance Summary

Total Return+106.50%
Annualized Return+19.41%
Volatility+15.30%
Sharpe Ratio1.14
Max Drawdown+23.89%

Holdings

Asset Allocation

Asset Class

Equity 100.0%
Holdings Details
Diversified global equity portfolio with core US S&P 500 and All-World ETFs, plus targeted allocations to semiconductor and space innovation sectors.
AssetTypeAllocationTER
VUAA.XETRA
Vanguard S&P 500 UCITS ETF (USD) AccumulatingIE00BFMXXD54
ETF
72.0%0.07%
VWCE.XETRA
Vanguard FTSE All-World UCITS ETF (USD) AccumulatingIE00BK5BQT80
ETF
19.0%0.19%
VVSM.XETRA
VanEck Semiconductor UCITS ETFIE00BMC38736
ETF
6.0%0.35%
JEDI.XETRA
VanEck Space Innovators UCITS ETFIE000YU9K6K2
ETF
3.0%0.55%
Total100.0%0.12%

Performance

Portfolio Value Over Time
Starting with 10,000 investment → now worth €20,650.36
Histogram of Monthly Returns
The portfolio had a positive return during 30 of the 50 months (60%)
Monthly Returns Heatmap
Best month: +12.7% • Worst month: -8.9% • Best year: 2024 (+31.4%) • Worst year: 2022 (-1.1%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026+2.6%-0.4%-4.2%+12.7%+10.5%+1.0%-5.3%-----+16.7%
2025+4.0%-3.8%-8.9%-5.0%+7.3%+2.9%+5.9%-0.7%+3.7%+6.0%-1.3%+0.9%+9.9%
2024+3.7%+4.7%+3.8%-2.2%+1.6%+6.8%-0.8%-0.9%+1.7%+1.9%+8.3%-0.5%+31.4%
2023+5.1%+0.9%+0.6%-0.6%+5.0%+3.9%+2.3%+0.0%-2.3%-3.5%+6.3%+4.6%+24.0%
2022------0.9%+11.0%-1.6%-6.0%+4.5%-0.8%-6.3%-1.1%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +23.89% • The longest drawdown period lasted for 11 months and was between August 2022 and July 2023. It reached a trough of -14.6%.

Detailed Metrics

Returns
Total Return
+106.50%
Annualized Return
+19.41%
Avg Monthly Return
+1.56%
Risk
Volatility (Annual)
+15.30%
Max Drawdown
+23.89%
Positive Months
60%
Average Drawdown
-4.8%
Risk-Adjusted
Sharpe Ratio
1.14
Risk-free rate: 2.0%
Sortino Ratio
1.08
Downside risk adjusted
Return/Volatility
1.27
Calmar Ratio
0.81
Return/Max Drawdown
Ulcer Index
6.09
Drawdown depth & duration
Martin Ratio
0.03
Return/Ulcer Index
Backtest Configuration
Initial Investment
10,000
Final Value
20,650.36
Backtest Period
2022-06-29 to 2026-07-31
4.1 years
Rebalancing
none
Base Currency
EUR